FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mauro Podda

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Michelle M Mitchell; Ana Lleo; Luca Zammataro; Marlyn J Mayo; Pietro Invernizzi; Nancy Bach; Shinji Shimoda; Stuart Gordon; Mauro Podda; M Eric Gershwin; Carlo Selmi; Janine M LaSalle
Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis.
Haiying Liu; Gary L Norman; Zakera Shums; Howard J Worman; Edward L Krawitt; Nicola Bizzaro; Diego Vergani; Dimitrios P Bogdanos; George N Dalekos; Piotr Milkiewicz; Albert J Czaja; E Jenny Heathcote; Gideon M Hirschfield; Eng M Tan; Kiyomitsu Miyachi; Monica Bignotto; Pier Maria Battezzati; Ana Lleo; Patrick S C Leung; Mauro Podda; M Eric Gershwin; Pietro Invernizzi
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
Lorenzo Montali; Atsushi Tanaka; Paolo Riva; Hiroki Takahashi; Claudio Cocchi; Yoshiyuki Ueno; Massimo Miglioretti; Hajime Takikawa; Luca Vecchio; Alessandra Frigerio; Ilaria Bianchi; Roberta Jorgensen; Keith D Lindor; Mauro Podda; Pietro Invernizzi
A short version of a HRQoL questionnaire for Italian and Japanese patients with Primary Biliary Cirrhosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mauro Podda (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Michelle M Mitchell; Ana Lleo; Luca Zammataro; Marlyn J Mayo; Pietro Invernizzi; Nancy Bach; Shinji Shimoda; Stuart Gordon; Mauro Podda; M Eric Gershwin; Carlo Selmi; Janine M LaSalle
Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis.
Epigenetics : official journal of the DNA Methylation Society 2011;6(1):95-102.
2010: Haiying Liu; Gary L Norman; Zakera Shums; Howard J Worman; Edward L Krawitt; Nicola Bizzaro; Diego Vergani; Dimitrios P Bogdanos; George N Dalekos; Piotr Milkiewicz; Albert J Czaja; E Jenny Heathcote; Gideon M Hirschfield; Eng M Tan; Kiyomitsu Miyachi; Monica Bignotto; Pier Maria Battezzati; Ana Lleo; Patrick S C Leung; Mauro Podda; M Eric Gershwin; Pietro Invernizzi
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
Journal of autoimmunity 2010;35(4):436-42.
2010: Lorenzo Montali; Atsushi Tanaka; Paolo Riva; Hiroki Takahashi; Claudio Cocchi; Yoshiyuki Ueno; Massimo Miglioretti; Hajime Takikawa; Luca Vecchio; Alessandra Frigerio; Ilaria Bianchi; Roberta Jorgensen; Keith D Lindor; Mauro Podda; Pietro Invernizzi
A short version of a HRQoL questionnaire for Italian and Japanese patients with Primary Biliary Cirrhosis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2010;42(10):718-23.
2010: Ana Lleo; Christopher L Bowlus; Guo-Xiang Yang; Pietro Invernizzi; Mauro Podda; Judith A van de Water; Aftab A Ansari; Ross L Coppel; Howard J Worman; Gregory J Gores; M Eric Gershwin
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2010;52(3):987-98.
2010: Gabriella Cerri; Claudio A Cocchi; Marcella Montagna; Massimo Zuin; Mauro Podda; Paolo Cavallari; Carlo Selmi
Patients with primary biliary cirrhosis do not show post-exercise depression of cortical excitability.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2010;121(8):1321-8.
2010: Ana Lleo; Pietro Invernizzi; Bin Gao; Mauro Podda; M Eric Gershwin
Definition of human autoimmunity--autoantibodies versus autoimmune disease.
Autoimmunity reviews 2010;9(5):A259-66.
2010: Sabine Oertelt-Prigione; Andrea Crosignani; Maurizio Gallieni; Emanuela Vassallo; Mauro Podda; Massimo Zuin
Severe hepatic encephalopathy in a patient with liver cirrhosis after administration of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker combination therapy: a case report.
Journal of medical case reports 2010;4():141.
2010: Carlo Selmi; Francesca Meda; Anaid Kasangian; Pietro Invernizzi; Zhigang Tian; Zhexiong Lian; Mauro Podda; M Eric Gershwin
Experimental evidence on the immunopathogenesis of primary biliary cirrhosis.
Cellular & molecular immunology 2010;7(1):1-10.
2009: Alessia Giorgini; Franco Capsoni; Mauro Podda; Ana Lleó; Pier Maria Battezzati; Anna Maria Ongari; Carlo Selmi; Alberto Benetti; Federica Malinverno; Lorenzo Rossaro; M Eric Gershwin; Massimo Zuin
Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis.
Annals of the New York Academy of Sciences 2009;1173():847-57.
2009: Massimo Zuin; Alessia Giorgini; Carlo Selmi; Pier Maria Battezzati; C A Cocchi; Andrea Crosignani; A Benetti; Pietro Invernizzi; Mauro Podda
Acute liver and renal failure during treatment with buprenorphine at therapeutic dose.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2009;41(7):e8-e10.
2009: Ana Lleo; Carlo Selmi; Pietro Invernizzi; Mauro Podda; Ross Coppel; Ian R Mackay; Gregory J Gores; Aftab A Ansari; Judith A van de Water; M Eric Gershwin
Apotopes and the biliary specificity of primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2009;49(3):871-9.
2008: Pietro Invernizzi; Carlo Selmi; Francesca Poli; Sara Frison; Annarosa Floreani; Domenico Alvaro; Piero Luigi Almasio; Floriano Rosina; Marco Marzioni; Luca Fabris; Luigi Muratori; Lihong Qi; Michael F Seldin; M Eric Gershwin; Mauro Podda
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls.
Hepatology (Baltimore, Md.) 2008;48(6):1906-12.
2008: Ana Lleo; Carlo Selmi; Pietro Invernizzi; Mauro Podda; M Eric Gershwin
The consequences of apoptosis in autoimmunity.
Journal of autoimmunity 2008;31(3):257-62.
2008: Pietro Invernizzi; Simone Pasini; Mauro Podda
X chromosome in autoimmune diseases.
Expert review of clinical immunology 2008;4(5):591-7.
2008: Ana Lleo; Pier Maria Battezzati; Carlo Selmi; M Eric Gershwin; Mauro Podda
Is autoimmunity a matter of sex?
Autoimmunity reviews 2008;7(8):626-30.
2008: Andrea Crosignani; Pier Maria Battezzati; Pietro Invernizzi; Carlo Selmi; Elena Prina; Mauro Podda
Clinical features and management of primary biliary cirrhosis.
World journal of gastroenterology : WJG 2008;14(21):3313-27.
2008: Pietro Invernizzi; Simone Pasini; Carlo Selmi; Monica Miozzo; Mauro Podda
Skewing of X chromosome inactivation in autoimmunity.
Autoimmunity 2008;41(4):272-7.
2008: Anna Benetti; Andrea Crosignani; Massimo Varenna; Cristina Squarcia Giussani; Mariangela Allocca; Massimo Zuin; Mauro Podda; Pier Maria Battezzati
Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study.
Journal of clinical gastroenterology 2008;42(3):306-11.
2008: Sabine Oertelt-Prigione; Tin K Mao; Carlo Selmi; Koichi tsuneyama; Aftab A Ansari; Ross Coppel; Pietro Invernizzi; Mauro Podda; M Eric Gershwin
Impaired indoleamine 2,3-dioxygenase production contributes to the development of autoimmunity in primary biliary cirrhosis.
Autoimmunity 2008;41(1):92-9.
2007: Pietro Invernizzi; Monica Miozzo; Sabine Oertelt-Prigione; Pier Luigi Meroni; Luca Persani; Carlo Selmi; Pier Maria Battezzati; Massimo Zuin; Simona Lucchi; Bianca Marasini; Silvana Zeni; Mitchell Watnik; Silvia Tabano; Silvia Maitz; Simone Pasini; M Eric Gershwin; Mauro Podda
X monosomy in female systemic lupus erythematosus.
Annals of the New York Academy of Sciences 2007;1110():84-91.
2007: Ana Lleo; Pietro Invernizzi; Carlo Selmi; Ross Coppel; Gianfranco Alpini; Mauro Podda; Ian R Mackay; M Eric Gershwin
Autophagy: highlighting a novel player in the autoimmunity scenario.
Journal of autoimmunity 2007;29(2-3):61-8.
2007: Monica Miozzo; Carlo Selmi; Barbara Gentilin; Francesca R Grati; Silvia M Sirchia; Sabine Oertelt; Massimo Zuin; M Eric Gershwin; Mauro Podda; Pietro Invernizzi
Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2007;46(2):456-62.
2007: Andrea Crosignani; Marina Del Puppo; Matteo Longo; Emma De Fabiani; Donatella Caruso; Massimo Zuin; Mauro Podda; Norman B Javitt; Marzia Galli Kienle
Changes in classic and alternative pathways of bile acid synthesis in chronic liver disease.
Clinica chimica acta; international journal of clinical chemistry 2007;382(1-2):82-8.
2007: Silvia Della Bella; Andrea Crosignani; Antonio Riva; Pietro Presicce; Anna Benetti; Renato Longhi; Mauro Podda; Maria Luisa Villa
Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection.
Immunology 2007;121(2):283-92.
2007: Pietro Invernizzi; Ana Lleo; Mauro Podda
Interpreting serological tests in diagnosing autoimmune liver diseases.
Seminars in liver disease 2007;27(2):161-72.
2007: Sabine Oertelt; Roman Rieger; Carlo Selmi; Pietro Invernizzi; Aftab A Ansari; Ross Coppel; Mauro Podda; Patrick S C Leung; M Eric Gershwin
A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2007;45(3):659-65.
2007: Mariangela Allocca; Andrea Crosignani; Angela Gritti; Anna Benetti; Massimo Zuin; Mauro Podda; Pier Maria Battezzati
Inadequate dietary intake but not renal tubular acidosis is associated with bone demineralization in primary biliary cirrhosis.
Alimentary pharmacology & therapeutics 2007;25(2):219-27.
2006: Mariangela Allocca; Andrea Crosignani; Angela Gritti; Giorgio Ghilardi; D Gobatti; D Caruso; Massimo Zuin; Mauro Podda; Pier Maria Battezzati
Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis.
Gut 2006;55(12):1795-800.
2006: Carlo Selmi; Ana Lleo; Massimo Zuin; Mauro Podda; Lorenzo Rossaro; M Eric Gershwin
Interferon alpha and its contribution to autoimmunity.
Current opinion in investigational drugs (London, England : 2000) 2006;7(5):451-6.
2006: Józefa Wesierska-Gadek; Edward Penner; Pier Maria Battezzati; Carlo Selmi; Massimo Zuin; Eva Hitchman; Howard J Worman; M Eric Gershwin; Mauro Podda; Pietro Invernizzi
Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2006;43(5):1135-44.
2005: Sabine Oertelt; Thomas P Kenny; Carlo Selmi; Pietro Invernizzi; Mauro Podda; M Eric Gershwin
SNP analysis of genes implicated in T cell proliferation in primary biliary cirrhosis.
Clinical & developmental immunology 2005;12(4):259-63.
2005: Carlo Selmi; Pietro Invernizzi; Massimo Zuin; Mauro Podda; Michael F Seldin; M Eric Gershwin
Genes and (auto)immunity in primary biliary cirrhosis.
Genes and immunity 2005;6(7):543-56.
2005: Sabine Oertelt; Carlo Selmi; Pietro Invernizzi; Mauro Podda; M Eric Gershwin
Genes and goals: an approach to microarray analysis in autoimmunity.
Autoimmunity reviews 2005;4(7):414-22.
2005: Pietro Invernizzi; Carlo Selmi; Carmen Ranftler; Mauro Podda; Józefa Wesierska-Gadek
Antinuclear antibodies in primary biliary cirrhosis.
Seminars in liver disease 2005;25(3):298-310.
2005: Carlo Selmi; Pietro Invernizzi; Massimo Zuin; Mauro Podda; M Eric Gershwin
Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology.
Seminars in liver disease 2005;25(3):265-80.
2005: Pietro Invernizzi; Monica Miozzo; Carlo Selmi; Luca Persani; Pier Maria Battezzati; Massimo Zuin; Simona Lucchi; Pier Luigi Meroni; Bianca Marasini; Silvana Zeni; Mitchell Watnik; Francesca R Grati; Giuseppe Simoni; M Eric Gershwin; Mauro Podda
X chromosome monosomy: a common mechanism for autoimmune diseases.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(1):575-8.
2005: Roman Rieger; Sabine Oertelt; Carlo Selmi; Pietro Invernizzi; Mauro Podda; M Eric Gershwin
Decreased serum leptin levels in primary biliary cirrhosis: a link between metabolism and autoimmunity?
Annals of the New York Academy of Sciences 2005;1051():211-7.
2005: Sabine Oertelt; Pietro Invernizzi; Carlo Selmi; Mauro Podda; M Eric Gershwin
Soluble CD40L in plasma of patients with primary biliary cirrhosis.
Annals of the New York Academy of Sciences 2005;1051():205-10.
2005: Alessia Giorgini; Carlo Selmi; Pietro Invernizzi; Mauro Podda; Massimo Zuin; M Eric Gershwin
Primary biliary cirrhosis: solving the enigma.
Annals of the New York Academy of Sciences 2005;1051():185-93.
2005: Kentaro Kikuchi; Zhe-Xiong Lian; Yasuhiko Kimura; Carlo Selmi; Guo-Xiang Yang; Stuart Gordon; Pietro Invernizzi; Mauro Podda; Ross Coppel; Aftab A Ansari; Susumu Ikehara; Hiroshi Miyakawa; M Eric Gershwin
Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis.
Journal of autoimmunity 2005;24(4):347-52.
2005: Pietro Invernizzi; Carlo Selmi; Ian R Mackay; Mauro Podda; M Eric Gershwin
From bases to basis: linking genetics to causation in primary biliary cirrhosis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005;3(5):401-10.
2005: Marina Del Puppo; Andrea Crosignani; Matteo Longo; Massimo Zuin; Mauro Podda; Giovanni Galli; Emma De Fabiani; Pierangela Ciuffreda; Enzo Santaniello; Norman B Javitt; Marzia Galli Kienle
A minimally invasive technique for the evaluation of the regulatory steps of the two major pathways of bile acid synthesis.
Clinica chimica acta; international journal of clinical chemistry 2005;355(1-2):23-31.
2005: Carlo Selmi; Yasunori Ichiki; Pietro Invernizzi; Mauro Podda; M Eric Gershwin
The enigma of primary biliary cirrhosis.
Clinical reviews in allergy & immunology 2005;28(2):73-81.
2005: Yasuhiko Kimura; Carlo Selmi; Patrick S C Leung; Tin K Mao; Joseph Schauer; Mitchell Watnik; Shigeki Kuriyama; Mikio Nishioka; Aftab A Ansari; Ross Coppel; Pietro Invernizzi; Mauro Podda; M Eric Gershwin
Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2005;41(1):55-63.
2004: Carlo Selmi; Pietro Invernizzi; Monica Miozzo; Mauro Podda; M Eric Gershwin
Primary biliary cirrhosis: does X mark the spot?
Autoimmunity reviews 2004;3(7-8):493-9.
2004: Carlo Selmi; Susan R Ross; Aftab A Ansari; Pietro Invernizzi; Mauro Podda; Ross Coppel; M Eric Gershwin
Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis.
Gastroenterology 2004;127(2):493-501.
2004: Carlo Selmi; Marlyn J Mayo; Nancy Bach; Hiromi Ishibashi; Pietro Invernizzi; Robert G Gish; Stuart Gordon; Harlan I Wright; Bruce Zweiban; Mauro Podda; M Eric Gershwin
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment.
Gastroenterology 2004;127(2):485-92.
2004: Carlo Selmi; Pietro Invernizzi; Emmet B Keeffe; Ross Coppel; Mauro Podda; Lorenzo Rossaro; Aftab A Ansari; M Eric Gershwin; Emmet B Keefe
Epidemiology and pathogenesis of primary biliary cirrhosis.
Journal of clinical gastroenterology 2004;38(3):264-71.
2004: Pietro Invernizzi; Monica Miozzo; Pier Maria Battezzati; Ilaria Bianchi; Francesca R Grati; Giuseppe Simoni; Carlo Selmi; Mitchell Watnik; M Eric Gershwin; Mauro Podda
Frequency of monosomy X in women with primary biliary cirrhosis.
Lancet 2004;363(9408):533-5.
2003: Carlo Selmi; David L Balkwill; Pietro Invernizzi; Aftab A Ansari; Ross Coppel; Mauro Podda; Patrick S C Leung; Thomas P Kenny; Judith A van de Water; Michael H Nantz; Mark J Kurth; M Eric Gershwin
Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium.
Hepatology (Baltimore, Md.) 2003;38(5):1250-7.
2003: Roberto Santambrogio; Mauro Podda; Massimo Zuin; E Bertolini; Savino Bruno; Gian Paolo Cornalba; Mara Costa; Marco Montorsi
Safety and efficacy of laparoscopic radiofrequency ablation of hepatocellular carcinoma in patients with liver cirrhosis.
Surgical endoscopy 2003;17(11):1826-32.
2003: Carlo Selmi; Massimo Zuin; Maria Luisa Biondi; Pietro Invernizzi; Pier Maria Battezzati; Mara Bernini; Francesca Meda; M Eric Gershwin; Mauro Podda
Genetic variants of endothelial nitric oxide synthase in patients with primary biliary cirrhosis: association with disease severity.
Journal of gastroenterology and hepatology 2003;18(10):1150-5.
2003: Tauro M Neri; Giulia Martina Cavestro; Pietro Seghini; Paola Francesca Zanelli; Adele Zanetti; Mario Savi; Mauro Podda; Massimo Zuin; M Colombo; A Floreani; Floriano Rosina; G Bianchi Porro; Mario Strazzabosco; Lajos Okolicsanyi
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2003;35(8):571-6.
2003: Carlo Selmi; Pietro Invernizzi; Pasquale Tripputi; Pier Maria Battezzati; Monica Bignotto; Massimo Zuin; Andrea Crosignani; Mauro Podda
T-cell receptor polymorphism in primary biliary cirrhosis.
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 2003;18(3):149-53.
2003: Saif Abu-Mouch; Carlo Selmi; Gordon D Benson; Thomas P Kenny; Pietro Invernizzi; Massimo Zuin; Mauro Podda; Lorenzo Rossaro; M Eric Gershwin
Geographic clusters of primary biliary cirrhosis.
Clinical & developmental immunology 2003;10(2-4):127-31.
2003: Lajos Okolicsanyi; M Groppo; A Floreani; A M Morselli-Labate; A G Rusticali; A Battocchia; M Colombo; Giovanni Galatola; G Gasbarrini; Mauro Podda; G Ricci; Floriano Rosina; Massimo Zuin
Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2003;35(5):325-31.
2003: Silvia Fargion; Savino Bruno; Mauro Borzio; Pier Maria Battezzati; Franco Bissoli; Roberto Ceriani; Annarosa Orlandi; Alessandra Maraschi; Alberto Chiesa; Lorenzo Morini; Anna Ludovica Fracanzani; Andrea Crosignani; Gemino Fiorelli; Mauro Podda
Sustained response to combination therapy in patients with chronic hepatitis C who failed to respond to interferon.
Journal of hepatology 2003;38(4):499-505.
2003: Pietro Invernizzi; Pier Maria Battezzati; Andrea Crosignani; Francesca Perego; Francesca Poli; Alberto Morabito; Alejandro Espadas De Arias; Mario Scalamogna; Massimo Zuin; Mauro Podda
Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis.
Journal of hepatology 2003;38(4):401-6.
2002: Alberto Larghi; Massimo Zuin; Andrea Crosignani; Maria Lisa Ribero; Cristina Pipia; Pier Maria Battezzati; Giorgio Binelli; Francesco Donato; Alessandro R Zanetti; Mauro Podda; Alessandro Tagger
Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies.
Hepatology (Baltimore, Md.) 2002;36(4 Pt 1):993-1000.
2002: Carlo Selmi; Aftab A Ansari; Pietro Invernizzi; Mauro Podda; M Eric Gershwin
The search for a practical approach to emerging diseases: the case of severe acute respiratory syndrome (SARS).
Developmental immunology 2002;9(3):113-7.
2002: M Longo; Andrea Crosignani; Pier Maria Battezzati; C Squarcia Giussani; Pietro Invernizzi; Massimo Zuin; Mauro Podda
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis.
Gut 2002;51(2):265-9.
2002: Pietro Invernizzi; Maria Luisa Biondi; Pier Maria Battezzati; Francesca Perego; Carlo Selmi; Federica Cecchini; Mauro Podda; Giuseppe Simoni
Presence of fetal DNA in maternal plasma decades after pregnancy.
Human genetics 2002;110(6):587-91.
2002: Marco Montorsi; Roberto Santambrogio; Paolo Pietro Bianchi; Giovanni Dapri; Antonino Spinelli; Mauro Podda
Perspectives and drawbacks of minimally invasive surgery for hepatocellular carcinoma.
Hepato-gastroenterology 2002;49(43):56-61.
2001: Pier Maria Battezzati; Massimo Zuin; Andrea Crosignani; Mariangela Allocca; Pietro Invernizzi; Carlo Selmi; E Villa; Mauro Podda
Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients.
Alimentary pharmacology & therapeutics 2001;15(9):1427-34.
2001: Savino Bruno; Pier Maria Battezzati; Giorgio Bellati; aldo manzin; Marco Maggioni; Andrea Crosignani; Mauro Borzio; L Solforosi; Alberto Morabito; G Ideo; Mauro Podda
Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C.
Journal of hepatology 2001;34(5):748-55.
2001: Marco Montorsi; Roberto Santambrogio; Paolo Pietro Bianchi; Enrico Opocher; Gian Paolo Cornalba; Giovanni Dapri; Luigi Bonavina; Massimo Zuin; Mauro Podda
Laparoscopy with laparoscopic ultrasound for pretreatment staging of hepatocellular carcinoma: a prospective study.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2001;5(3):312-5.
2001: Pietro Invernizzi; Mauro Podda; Pier Maria Battezzati; Andrea Crosignani; Massimo Zuin; Eva Hitchman; Marco Maggioni; P L Meroni; Edward Penner; Józefa Wesierska-Gadek
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis.
Journal of hepatology 2001;34(3):366-72.
2001: Marina Del Puppo; M Galli Kienle; Andrea Crosignani; Maria Letizia Petroni; B Amati; Massimo Zuin; Mauro Podda
Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration.
Journal of lipid research 2001;42(3):437-41.
2001: Marco Montorsi; Roberto Santambrogio; Paolo Pietro Bianchi; Enrico Opocher; Massimo Zuin; E Bertolini; Savino Bruno; Mauro Podda
Radiofrequency interstitial thermal ablation of hepatocellular carcinoma in liver cirrhosis. Role of the laparoscopic approach.
Surgical endoscopy 2001;15(2):141-5.
2001: Marco Montorsi; Roberto Santambrogio; Paolo Pietro Bianchi; Enrico Opocher; B Tagliaferri; Massimo Zuin; E Bertolini; Mauro Podda
Laparoscopic radiofrequency of hepatocellular carcinoma (HCC) in liver cirrhosis.
Hepato-gastroenterology 2001;48(37):41-5.
2001: antonio chiappa; Andrew P Zbar; Mauro Podda; Riccardo A Audisio; Emilio Bertani; Francesca Biella; Carlo T Paties; Carlo Staudacher
Prognostic value of the modified TNM (Izumi) classification of hepatocellular carcinoma in 53 cirrhotic patients undergoing resection.
Hepato-gastroenterology 2001;48(37):229-34.
2001: Maria Letizia Petroni; RP Jazrawi; Paolo Pazzi; Alberto Lanzini; Massimo Zuin; M G Pigozzi; Mario Fracchia; Giovanni Galatola; Vittorio Alvisi; K W Heaton; Mauro Podda; Timothy C Northfield
Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial. The British-Italian Gallstone Study group.
Alimentary pharmacology & therapeutics 2001;15(1):123-8.
2000: Pietro Invernizzi; C De Andreis; Silvia M Sirchia; Pier Maria Battezzati; Massimo Zuin; Franca Rossella; Francesca Perego; Monica Bignotto; Giuseppe Simoni; Mauro Podda
Blood fetal microchimerism in primary biliary cirrhosis.
Clinical and experimental immunology 2000;122(3):418-22.
2000: Massimo Zuin; Mauro Podda; Carlo Selmi; Alessia Giorgini; P Zermiani; G Mandelli; A C Sacchetta; C Candiani
Gastrointestinal tolerability of ibuprofen administered in two pharmaceutical formulations.
Arzneimittel-Forschung 2000;50(9):837-42.
2000: Maria Letizia Petroni; RP Jazrawi; Paolo Pazzi; Massimo Zuin; Alberto Lanzini; Mario Fracchia; D Facchinetti; Vittorio Alvisi; Roberto Ferraris; JM Bland; K W Heaton; Mauro Podda; Timothy C Northfield
Risk factors for the development of gallstone recurrence following medical dissolution. The British-Italian Gallstone Study Group.
European journal of gastroenterology & hepatology 2000;12(6):695-700.
1999: Alessandro Tagger; Maria Lisa Ribero; Alberto Larghi; Francesco Donato; Massimo Zuin; R Chiesa; G Benetti; G Ramella; Mauro Borzio; Mauro Podda
Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease.
The American journal of gastroenterology 1999;94(2):484-8.
1999: Pietro Invernizzi; Kenneth D R Setchell; Andrea Crosignani; Pier Maria Battezzati; Alberto Larghi; N C O'Connell; Mauro Podda
Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1999;29(2):320-7.
1999: Andrea Crosignani; Pietro Invernizzi; R Ferrari; aldo manzin; S Bruno; Massimo Zuin; F B Bianchi; Mauro Podda
Exacerbation of chronic hepatitis D during interferon alpha administration.
Italian journal of gastroenterology and hepatology 1999;31(1):66-9.
1998: Pietro Invernizzi; Pier Maria Battezzati; Andrea Crosignani; P Zermiani; Monica Bignotto; N Del Papa; Massimo Zuin; Mauro Podda
Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status.
Clinical and experimental immunology 1998;114(3):448-54.
1998: Marina Del Puppo; Marzia Galli Kienle; Maria Letizia Petroni; Andrea Crosignani; Mauro Podda
Serum 27-hydroxycholesterol in patients with primary biliary cirrhosis suggests alteration of cholesterol catabolism to bile acids via the acidic pathway.
Journal of lipid research 1998;39(12):2477-82.
1998: Andrea Crosignani; gabriele budillon; Lucia Cimino; Camillo del Vecchio-Blanco; Carmela Loguercio; G Ideo; G Raimondo; R Stabilini; Mauro Podda
Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled study.
Hepato-gastroenterology 1998;45(23):1624-9.
1998: Alberto Larghi; Alessandro Tagger; Andrea Crosignani; Maria Lisa Ribero; S Bruno; Giorgio Portera; Pier Maria Battezzati; Marco Maggioni; M Fasola; Massimo Zuin; Mauro Podda
Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy.
Journal of medical virology 1998;55(1):7-11.
1997: Maria Teresa Bardella; Maurizio Quatrini; Massimo Zuin; Mauro Podda; L Cesarini; Pietro Velio; P Bianchi; Dario Conte
Screening patients with celiac disease for primary biliary cirrhosis and vice versa.
The American journal of gastroenterology 1997;92(9):1524-6.
1997: Alberto Larghi; Andrea Crosignani; Pier Maria Battezzati; G De Valle; Mariangela Allocca; Pietro Invernizzi; Massimo Zuin; Mauro Podda
Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study.
Alimentary pharmacology & therapeutics 1997;11(2):409-14.
1997: Savino Bruno; Enrico Silini; Andrea Crosignani; Franco Borzio; Gioacchino Leandro; F Bono; M Asti; S Rossi; Alberto Larghi; Antonella Cerino; Mauro Podda; Mario U Mondelli
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study.
Hepatology (Baltimore, Md.) 1997;25(3):754-8.
1997: S Bruno; aldo manzin; Massimo Roncalli; Maria Letizia Petroni; S Rossi; M Pedicino; Alberto Larghi; Andrea Crosignani; Mauro Podda
Histological changes but not virus eradication reflect biochemical improvement in chronic hepatitis C patients showing a long-term response to interferon alpha therapy.
Italian journal of gastroenterology and hepatology 1997;29(1):31-7.
1996: Maria Letizia Petroni; RP Jazrawi; A Lanzini; Massimo Zuin; Paolo Pazzi; Mario Fracchia; E Boga; D Facchinetti; Vittorio Alvisi; Giovanni Galatola; J M Bland; K W Heaton; Mauro Podda; Timothy C Northfield
Repeated bile acid therapy for the long-term management of cholesterol gallstones.
Journal of hepatology 1996;25(5):719-24.
1996: C Colombo; Pier Maria Battezzati; Mauro Podda; N Bettinardi; Annamaria Giunta
Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.
Hepatology (Baltimore, Md.) 1996;23(6):1484-90.
1996: Andrea Crosignani; Kenneth D R Setchell; Pietro Invernizzi; Alberto Larghi; Cecília M P Rodrigues; Mauro Podda
Clinical pharmacokinetics of therapeutic bile acids.
Clinical pharmacokinetics 1996;30(5):333-58.
1996: Mario Fracchia; K D Setchell; Andrea Crosignani; Mauro Podda; N O'Connell; Roberto Ferraris; A F Hofmann; Giovanni Galatola
Bile acid conjugation in early stage cholestatic liver disease before and during treatment with ursodeoxycholic acid.
Clinica chimica acta; international journal of clinical chemistry 1996;248(2):175-85.
1996: Andrea Crosignani; Pier Maria Battezzati; Kenneth D R Setchell; Pietro Invernizzi; G Covini; Massimo Zuin; Mauro Podda
Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study.
Digestive diseases and sciences 1996;41(4):809-15.
1996: Kenneth D R Setchell; Cecília M P Rodrigues; Mauro Podda; Andrea Crosignani
Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis.
Gut 1996;38(3):439-46.
1996: Mauro Podda; Andrea Crosignani; Pier Maria Battezzati; M Quagliuolo; C Valsania; Pietro Invernizzi; Massimo Zuin
Ursodeoxycholic acid therapy in primary biliary cirrhosis.
The Italian journal of gastroenterology 1996;28(2):114-7.
1995: Mauro Borzio; Savino Bruno; Massimo Roncalli; G C Mels; G Ramella; Franco Borzio; Gioacchino Leandro; E Servida; Mauro Podda
Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study.
Gastroenterology 1995;108(3):812-7.
1994: M Camisasca; Andrea Crosignani; Pier Maria Battezzati; walter albisetti; G Grandinetti; L Pietrogrande; A Biffi; Massimo Zuin; Mauro Podda
Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 1994;20(3):633-7.
1994: C Colombo; Pier Maria Battezzati; Mauro Podda
Hepatobiliary disease in cystic fibrosis.
Seminars in liver disease 1994;14(3):259-69.
1994: Savino Bruno; S Rossi; Maria Letizia Petroni; Erica Villa; Massimo Zuin; Mauro Podda
Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus.
BMJ (Clinical research ed.) 1994;308(6930):697.
1993: Stefano Bellentani; Mauro Podda; Claudio Tiribelli; F Callea; M Marazzi; M Sodde; R Merlini; P M Batezzati; Andrea Crosignani; Massimo Zuin
Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial.
Journal of hepatology 1993;19(3):459-64.
1993: C Colombo; E Bertolini; M L Assaisso; N Bettinardi; Annamaria Giunta; Mauro Podda
Failure of ursodeoxycholic acid to dissolve radiolucent gallstones in patients with cystic fibrosis.
Acta paediatrica (Oslo, Norway : 1992) 1993;82(6-7):562-5.
1993: Pier Maria Battezzati; Mauro Podda; F B Bianchi; R Naccarato; F Orlandi; C Surrenti; L Pagliaro; F Manenti
Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC.
Journal of hepatology 1993;17(3):332-8.
1992: Pier Maria Battezzati; Mauro Podda; Savino Bruno; Massimo Zuin; Andrea Crosignani; M Camisasca; A Chiesa; Maria Letizia Petroni; A Russo; P Gallotti
Factors predicting early response to treatment with recombinant interferon alpha-2a in chronic non-A, non-B hepatitis. Preliminary report of a long-term trial.
The Italian journal of gastroenterology 1992;24(9):481-4.
1992: C Colombo; Andrea Crosignani; M Assaisso; Pier Maria Battezzati; Mauro Podda; Annamaria Giunta; Linda Zimmer-Nechemias; Kenneth D R Setchell
Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study.
Hepatology (Baltimore, Md.) 1992;16(4):924-30.
1992: Savino Bruno; Mauro Borzio; M Romagnoni; Pier Maria Battezzati; S Rossi; A Chiesa; Mauro Podda
Comparison of spontaneous ascites filtration and reinfusion with total paracentesis with intravenous albumin infusion in cirrhotic patients with tense ascites.
BMJ (Clinical research ed.) 1992;304(6843):1655-8.
1992: E Bertolini; F Marelli; P Zermiani; Pier Maria Battezzati; Massimo Zuin; G A Moroni; Mauro Podda
Antibodies to hepatitis C virus in primary biliary cirrhosis.
Archives of virology. Supplementum 1992;4():205-9.
1992: Mauro Podda; Massimo Roncalli; Pier Maria Battezzati; Mauro Borzio; Savino Bruno; E Servida; Guido Coggi
Liver-cell dysplasia and hepatocellular carcinoma.
The Italian journal of gastroenterology 1992;24(1):39-42.
1991: Andrea Crosignani; Mauro Podda; Pier Maria Battezzati; E Bertolini; Massimo Zuin; D Watson; Kenneth D R Setchell
Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.
Hepatology (Baltimore, Md.) 1991;14(6):1000-7.
1991: Andrea Crosignani; Mauro Podda; E Bertolini; Pier Maria Battezzati; Massimo Zuin; Kenneth D R Setchell
Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
Hepatology (Baltimore, Md.) 1991;13(6):1076-83.
1991: Mauro Borzio; Savino Bruno; Massimo Roncalli; G C Mels; G Ramella; Franco Borzio; Gioacchino Leandro; Mauro Podda
Liver cell dysplasia and risk of hepatocellular carcinoma in cirrhosis: a preliminary report.
BMJ (Clinical research ed.) 1991;302(6788):1312.
1991: E Bertolini; P Zermiani; Pier Maria Battezzati; Savino Bruno; Erica Villa; F Manenti; F Marelli; G A Moroni; Massimo Zuin; Mauro Podda
Lack of association between circulating HCV-RNA and anti-HCV positivity in primary biliary cirrhosis.
Lancet 1991;337(8742):675-6.
1991: Massimo Zuin; Maria Letizia Petroni; G Grandinetti; Andrea Crosignani; E Bertolini; Pier Maria Battezzati; Mauro Podda
Comparison of effects of chenodeoxycholic and ursodeoxycholic acid and their combination on biliary lipids in obese patients with gallstones.
Scandinavian journal of gastroenterology 1991;26(3):257-62.
1991: Andrea Crosignani; Pier Maria Battezzati; Kenneth D R Setchell; M Camisasca; E Bertolini; A Roda; Massimo Zuin; Mauro Podda
Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study.
Hepatology (Baltimore, Md.) 1991;13(2):339-44.
1990: C Colombo; Kenneth D R Setchell; Mauro Podda; Andrea Crosignani; A Roda; L Curcio; M Ronchi; Annamaria Giunta
Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.
The Journal of pediatrics 1990;117(3):482-9.
1990: Mauro Podda; C Ghezzi; Pier Maria Battezzati; Andrea Crosignani; Massimo Zuin; A Roda
Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis.
Gastroenterology 1990;98(4):1044-50.
1989: Mauro Podda; C Ghezzi; Pier Maria Battezzati; E Bertolini; Andrea Crosignani; Maria Letizia Petroni; Massimo Zuin
Effect of different doses of ursodeoxycholic acid in chronic liver disease.
Digestive diseases and sciences 1989;34(12 Suppl):59S-65S.
1989: Mauro Podda; Massimo Zuin; Pier Maria Battezzati; C Ghezzi; Cristina De Fazio; M L Dioguardi
Efficacy and safety of a combination of chenodeoxycholic acid and ursodeoxycholic acid for gallstone dissolution: a comparison with ursodeoxycholic acid alone.
Gastroenterology 1989;96(1):222-9.
1988: Mauro Podda; C Ghezzi; Pier Maria Battezzati; E Bertolini; Andrea Crosignani; Maria Letizia Petroni; Massimo Zuin
Ursodeoxycholic acid for chronic liver diseases.
Journal of clinical gastroenterology 1988;10 Suppl 2():S25-31.
1987: Massimo Zuin; Pier Maria Battezzati; M Camisasca; D Riebenfeld; Mauro Podda
Effects of a preparation containing a standardized ginseng extract combined with trace elements and multivitamins against hepatotoxin-induced chronic liver disease in the elderly.
The Journal of international medical research 1987;15(5):276-81.
1982: Mauro Podda; Massimo Zuin; M L Dioguardi; S Festorazzi
Successful treatment of gallstones with bile acids in obese adolescents.
Archives of disease in childhood 1982;57(12):956-8.
1982: Mauro Podda; Massimo Zuin; M L Dioguardi; S Festorazzi; N Dioguardi
A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
Hepatology (Baltimore, Md.) 1982;2(3):334-9.
1982: Mauro Podda; Massimo Zuin; Nicola Carulli; M Ponz de Leon; M L Dioguardi
Gallstone dissolution after 6 months of ursodeoxycholic acid (UDCA): effectiveness of different doses.
The Journal of international medical research 1982;10(1):59-63.
1981: Massimo Zuin; M L Dioguardi; S Festorazzi; Mauro Podda
Effect of epomediol on bile flow and composition in normal rats and in rats with ethynylestradiol-induced cholestasis.
Il Farmaco; edizione pratica 1981;36(8):383-9.
1980: Mauro Podda; Massimo Zuin; M L Dioguardi; S Festorazzi; C Di Padova
Effect of dihydroxydibutylether (DHBE) on bile flow and composition in rats with ethynylestradiol-induced cholestasis.
Arzneimittel-Forschung 1980;30(12):2126-8.